Pdl Bio Pharma

PDL BioPharma, based in Fremont, CA, was a publicly traded company that recently underwent a plan of dissolution approved by its stockholders in August 2020. Following the filing of a certificate of dissolution in January 2021, the company continued its existence for the purpose of settling its business affairs, discharging liabilities, and distributing remaining assets to stockholders.

Utilizing safe harbor procedures outlined in the Delaware General Corporate Law, PDL BioPharma navigated the claims resolution process and made a cash distribution to its stockholders in May 2022. The company's common stock was voluntarily delisted from NASDAQ in December 2020, with final record date set for January 4, 2021, marking the conclusion of its trading activities.

Generated from the website